Skip to main content
Presentation
Phase II trial of dovitinib in recurrent glioblastoma.
Journal of Clinical Oncology (2015)
  • Manmeet Singh Ahluwalia, Cleveland Clinic
  • Nikolaos Papadantonakis, Cleveland Clinic
  • Vyshak Alva Venur, Cleveland Clinic
  • Cathy Schilero, Cleveland Clinic
  • David M. Peereboom, Cleveland Clinic
  • Glen Stevens, Cleveland Clinic
  • Steven Rosenfeld, Cleveland Clinic
  • Michael A. Vogelbaum, Cleveland Clinic
  • Paul Elson, Cleveland Clinic
  • Andrew B. Nixon, Duke University
  • Keith McCrae, Cleveland Clinic
Publication Date
May 20, 2015
DOI
10.1200/JCO.2015.33.15_SUPPL.2050
Citation Information
Manmeet Singh Ahluwalia, Nikolaos Papadantonakis, Vyshak Alva Venur, Cathy Schilero, et al.. "Phase II trial of dovitinib in recurrent glioblastoma." Journal of Clinical Oncology (2015)
Available at: http://works.bepress.com/manmeet-ahluwalia/414/